3 October 2013, 13:00-15:00 – Room S3, World Trade Organization (WTO)
An event on the occasion of the WTO Public Forum 2013, Geneva, Switzerland
In recent years, various mechanisms have been established or proposed that seek to achieve the twin goals of incentivising innovation in health technologies for diseases that disproportionately affect developing countries and of promoting access to those technologies. This session will present and discuss the practical experience of some of those mechanisms with a focus on how they are being used to-date to address both innovation and access.
Intellectual Property Division, WTO Secretariat
Business Development Director, Drugs for Neglected Diseases Initiative (DNDi)
Executive Director, Medicines Patent Pool (MPP)
Global Challenges Division, World Intellectual Property Organization (WIPO)
Director, Knowledge Ecology International (KEI)
|Panel discussants:||Manica Balasegaram
Executive Director, Doctors Without Borders (MSF) Access Campaign
First Secretary, Bolivian Permanent Mission to the WTO
Senior Vice President, F. Hoffman-La Roche, Ltd.